Cloud Banner

Pharmaceutical

Image

Global Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Jun 2023
  • Global
  • 350 Pages
  • No of Tables: 851
  • No of Figures: 71

Global Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 13.5% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 2477.81 Million
Diagram Market Size (Forecast Year) USD 6717.76 Million
Diagram CAGR 13.5%

Global Medical Foods for Inborn Errors of Metabolism Market, By Products (Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Low Protein Food, and Others), Age Group (Infants, Weaning, Adolescent, and Adults), Diseases (Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I, Renal Disease, Tyrosinemia Types I and II, Urea Cycle Disorders, and Others), Forms (Powder, Liquid, Tablets, Gels, and Others), Packaging (Can, Jar, Packets, Bottle, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Drug Stores, Online Pharmacy, and Others) – Industry Trends and Forecast to 2030.

Medical Foods for Inborn Errors of Metabolism Market

Medical Foods for Inborn Errors of Metabolism Market Analysis and Insights

The term Inborn Error of Metabolism (IEM) is used for a large group of genetic diseases. These diseases are exceptionally rare and they have an incidence of 1 in 2500 live births. Many of these diseases can be very severe and life-threatening if not treated properly within time and with the help of specific diets or other enzyme replacement or substitution therapies.

Medical Foods for Inborn Errors of Metabolism MarketMedical Foods for Inborn Errors of Metabolism Market

A rise in incidences of IEMs and the preference for dietary supplements over Enzyme Replacement Therapy (ERT) are expected to drive market growth.

The global medical foods for inborn errors of metabolism market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief. Our team will help you create a revenue-impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for safe distribution of machine and drugs products are the major drivers which propelled the demand of the market in the forecast period.

Data Bridge Market Research analyzes that the market is growing with a CAGR of 13.5% in the forecast period of 2023 to 2030 and is expected to reach USD 6,717.76 million by 2030 from USD 2,477.81 million in 2022.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Year

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million

Segments Covered

Products (Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Low Protein Food, and Others), Age Group (Infants, Weaning, Adolescent, and Adults), Diseases (Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I, Renal Disease, Tyrosinemia Types I and II, Urea Cycle Disorders, and Others), Forms (Powder, Liquid, Tablets, Gels, and Others), Packaging (Can, Jar, Packets, Bottle, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Drug Stores, Online Pharmacy, and Others)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Poland, Finland, Denmark, Sweden, Norway, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, New Zealand, Vietnam, Philippines, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, Bahrain, United Arab Emirates, Kuwait, Qatar, Egypt, Oman, and Rest of Middle East and Africa

Market Players Covered

Nestlé Health Science (A subsidiary of Nestle), Nutricia (A subsidiary of Danone), Baxter, Meiji Holdings Co., Ltd., Piam Farmaceutici S.P.A., Solace Nutrition, Abbott, Mead Johnson & Company, LLC. (A Subsidiary of Reckitt Benckiser Group plc.), Ajinomoto Cambrooke, Inc. (A Subsidiary of Ajinomoto Co., Inc.), Galen Limited, PKU-MDmil, Pristine Organics Private Limited, APR, Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA), PKU Perspectives, EBM Medical, Orpharma Pty Ltd., B. Braun SE, Primus Pharmaceuticals, Inc., Kate Farms, Hexagonnutrition Ltd., Ener-G Foods, Inc., Promin Metabolics, and Dr. Schär AG / SPA) among others  

Market Definition

The Inborn Errors of Metabolism (IEMs) are a group of disorders in which the body fails to convert food into energy. Due to mutations in genes, there is less or no production of specific enzymes, and these enzymes are responsible for breaking down certain substances. This breakdown leads to the accumulation of some toxic substances and results in severe complications. To treat these disorders, the concerned patients are given specific diets, which are also known as medical foods, under the supervision of physicians.

Global Medical Foods for Inborn Errors of Metabolism Market Dynamics

Drivers

  • Rising Incidence of Inborn Errors of Metabolism (IEM)

Inborn Errors of Metabolism (IEMs), also known as inherited metabolic disorders, are a group of rare genetic disorders caused by defects in certain enzymes or biochemical pathways responsible for the metabolism of various substances in the body. These disorders can affect any organ or system and produce a variety of symptoms.

Though these diseases are thought to be rare, collectively, they have a higher incidence rate. If they are not detected early, they may lead to serious consequences and, in some cases, fatality.

Thus, the rising incidences of IEMs are expected to drive market growth.

  • Rising Preference for Dietary Supplements over Enzyme Replacement Therapy (ERT)

The rising preference for dietary supplements over ERT in the treatment of IEMs may be due to several factors. Firstly, dietary supplements offer a non-invasive and convenient approach to treatment. Unlike ERT, which often involves an injection or infusion, supplements can be taken orally, making them more attractive to patients who want a less invasive option. In addition, food supplements provide comprehensive nutritional support, as they contain various nutrients, cofactors, and substrates necessary for optimal metabolism. This broader spectrum of support addresses several metabolic deficits associated with specific IEMs, which can lead to more effective management of the condition.

Thus, the rising preference for dietary supplements over ERT in the treatment of IEMs is expected to drive market growth.

Medical Foods for Inborn Errors of Metabolism Market

Opportunities

  • Government Initiatives and Programs for Creating Awareness About Inborn Errors of Metabolism

Governments around the world have recognized the importance of raising awareness about IEMs and have implemented various initiatives and programs to address this need. These initiatives aim to educate healthcare professionals, individuals and families affected by IEMs, and the general public, which is expected to provide opportunities for market growth.

  • Increasing Collaborations and Partnerships in the Market

Growing partnerships and collaborations in the market are changing the landscape, driving innovation, advancing R&D, and improving patient care. These collaborations bring together key stakeholders such as pharmaceutical companies, medical food manufacturers, research institutes, and patient advocacy groups. By combining their expertise, resources, and networks, these partnerships will accelerate the R&D of improved treatments and medicines for people with IEMs. In addition, the strategic initiatives taken by key market players are expected to provide structural integrity and future opportunities for market growth in the forecast period of 2023-2030.

Restraint/Challenge

  • High Cost of Medical Food

The high cost of medical foods is due to many factors that affect the cost of their production, development, and distribution. Special medical foods require extensive R&D. Manufacturers invest in scientific research and clinical trials to find the optimal combination of nutrients, bioactive compounds, and therapeutic agents to treat specific health conditions. This study involves the expertise of nutritionists, food and health professionals, which increases the total cost. Thus, the high cost of medical foods is expected to restrain market growth.

Recent Developments

  • In October 2022, Galen Limited introduced the first solid-dose protein substitution option for Tyrosinemia, called TYR EASY Tablets in the U.K. market. Tyrosinemia (TYR) patients over the age of 8 can now choose from a wider variety of protein substitutes that best suit their daily needs.
  • In July 2020, Baxter, a global leader in clinical nutrition, and VIPUN Medical, a company that develops technological solutions to improve medical nutrition, announced an agreement to commercialize VIPUN's gastric monitoring system. As part of the agreement, Baxter will support clinical trials necessary to obtain regulatory approval in key markets worldwide and global distribution rights.

Global Medical Foods for Inborn Errors of Metabolism Market Scope

The global medical foods for inborn errors of metabolism market is segmented into six notable segments based on products, age group, diseases, forms, packaging, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Products

  • Amino Acids
  • Glytactin With Gmp Amino Acid-Modified Infant Formula With Iron
  • Low-Calcium/Vitamin D-Free Infant Formula With Iron
  • Low Protein Food
  • Others

On the basis of products, the market is segmented into amino acid, glytactin with GMP amino acid-modified infant formula with iron, low-calcium/vitamin D-free infant formula with iron, low protein food, and others.

Diseases

  • Phenylketonuria (PKU)
  • Maple Syrup Urine Disease (MSUD)
  • Homocystinuria
  • Methylmalonic Acidemia
  • Organic Acidurias
  • Propionic Acidemia
  • Isovaleric Acidemia
  • Disorders of Leucine Metabolism
  • Glutaric Acidemia Type I
  • Renal Disease
  • Tyrosinemia Types I and II
  • Urea Cycle Disorders
  • Others

On the basis of diseases, the market is segmented into phenylketonuria (PKU), tyrosinemia types I And II, maple syrup urine disease (MSUD), homocystinuria, glutaric acidemia type I, urea cycle disorders, methylmalonic acidemia, isovaleric acidemia, organic acidurias, renal disease, propionic academia, disorders of leucine metabolism, and others.

Age Group

  • Infants
  • Weaning
  • Adolescent
  • Adults

On the basis of age group, the market is segmented into infants, weaning, adolescent, and adults.

Forms

  • Powder
  • Liquid
  • Tablets
  • Gels
  • Others

On the basis of forms, the market is segmented into powder, liquid, tablets, gels, and others.

Packaging

  • Can
  • Jar
  • Packets
  • Bottle
  • Others

On the basis of packaging, the market is segmented into can, jar, packets, bottle, and others.

Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • Drugs Stores
  • Others

On the basis of distribution channel, the market is segmented into retail pharmacy, hospital pharmacy, online pharmacy, drugs store, and others.

Medical Foods for Inborn Errors of Metabolism Market

Global Medical Foods for Inborn Errors of Metabolism Market Regional Analysis/Insights    

The global medical foods for inborn errors of metabolism market is segmented into six notable segments based on products, age group, diseases, forms, packaging, and distribution channel.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Poland, Finland, Denmark, Sweden, Norway, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, New Zealand, Vietnam, Philippines, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, Bahrain, United Arab Emirates, Kuwait, Qatar, Egypt, Oman, and Rest of Middle East and Africa.

North America is expected to dominate the global medical foods for inborn errors of metabolism market due to the presence of key market players in the largest consumer market with high GDP.  U.S. is expected to dominate the North America region due to the strong presence of key players such as Meiji Holdings Co., Ltd., Abbott, and Nestlé Health Science. Germany is expected to dominate the Europe region due to the mass production of medical foods and increasing demand from emerging markets and expansion. China is expected to dominate the Asia-Pacific region due to the increasing investment in R&D, which is expected to boost market growth.

The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.

Medical Foods for Inborn Errors of Metabolism Market

Competitive Landscape and Global Medical Foods for Inborn Errors of Metabolism Market Share Analysis

The global medical foods for inborn errors of metabolism market competitive landscape provides details about the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the market.

Some of the major market players operating in the global medical foods for inborn errors of metabolism market are Nestlé Health Science (A subsidiary of Nestle), Nutricia (A subsidiary of Danone), Baxter, Meiji Holdings Co., Ltd., Piam Farmaceutici S.P.A., Solace Nutrition, Abbott, Mead Johnson & Company, LLC. (A Subsidiary of Reckitt Benckiser Group plc.), Ajinomoto Cambrooke, Inc. (A Subsidiary of Ajinomoto Co., Inc.), Galen Limited, PKU-MDmil, Pristine Organics Private Limited, APR, Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA), PKU Perspectives, EBM Medical, Orpharma Pty Ltd., B. Braun SE, Primus Pharmaceuticals, Inc., Kate Farms, Hexagonnutrition Ltd., Ener-G Foods, Inc., Promin Metabolics, and Dr. Schär AG / SPA) among others.


SKU-

TABLE 1 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, PATENT ANALYSIS

TABLE 2 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, PIPELINE ANALYSIS

TABLE 3 COSTS OF MEDICAL FOODS USED IN INBORN ERRORS OF METABOLISM (IEMS)

TABLE 4 THE MANUFACTURING OF MEDICAL FOOD MUST COMPLY WITH THE BELOW GIVEN FDA REQUIREMENT:

TABLE 5 COSTS OF MEDICAL FOODS

TABLE 6 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-20307 (USD MILLION)

TABLE 7 GLOBAL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 8 GLOBAL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 9 GLOBAL AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 10 GLOBAL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 11 GLOBAL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 12 GLOBAL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 13 GLOBAL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 14 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVOURS, 2021-2030 (USD MILLION)

TABLE 16 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGE, 2021-2030 (USD MILLION)

TABLE 17 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 19 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 20 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 21 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 23 GLOBAL TYROSINEMIA TYPES I AND II IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 24 GLOBAL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 GLOBAL MAPLE SYRUP URINE DISEASE(MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2030 (USD MILLION)

TABLE 26 GLOBAL HOMOCYSTINURIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 GLOBAL GLUTARIC ACIDEMIA TYPE I IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 30 GLOBAL METHYLMALONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 31 GLOBAL ISOVALERIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 GLOBAL ORGANIC ACIDURIAS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 GLOBAL RENAL DISEASE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 34 GLOBAL PROPIONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 35 GLOBAL DISORDERS OF LEUCINE METABOLISM IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 36 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 37 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 38 GLOBAL INFANTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 GLOBAL WEANING IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 GLOBAL ADOLESCENT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 GLOBAL ADULTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 43 GLOBAL POWDER IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 GLOBAL LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 45 GLOBAL TABLETS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 GLOBAL GELS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 49 GLOBAL CAN IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 GLOBAL PACKETS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 GLOBAL BOTTLE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 52 GLOBAL JAR IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 54 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 55 GLOBAL HOSPITAL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 56 GLOBAL RETAIL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 GLOBAL DRUG STORES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 GLOBAL ONLINE PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 59 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 60 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 61 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 62 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 63 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 64 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 65 NORTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 66 NORTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 67 NORTH AMERICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 68 NORTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 69 NORTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 70 NORTH AMERICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 71 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 72 NORTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 73 NORTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 74 NORTH AMERICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 75 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 76 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 77 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 78 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 79 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 80 U.S. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 81 U.S. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 82 U.S. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 83 U.S. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 84 U.S. LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 85 U.S. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 86 U.S. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 87 U.S. LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 88 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 89 U.S. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 90 U.S. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 91 U.S. UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 92 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 93 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 94 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 95 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 96 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 97 CANADA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 98 CANADA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 99 CANADA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 100 CANADA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 101 CANADA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 102 CANADA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 103 CANADA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 104 CANADA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 105 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 106 CANADA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 107 CANADA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 108 CANADA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 109 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 110 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 111 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 112 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 113 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 114 MEXICO AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 115 MEXICO AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 116 MEXICO PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 117 MEXICO SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 118 MEXICO LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 119 MEXICO GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 120 MEXICO GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 121 MEXICO LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 122 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 123 MEXICO PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 124 MEXICO MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 125 MEXICO UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 126 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 127 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 128 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 129 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 130 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 131 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 132 EUROPE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 133 EUROPE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 134 EUROPE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 135 EUROPE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 136 EUROPE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 137 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 138 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 139 EUROPE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 140 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 141 EUROPE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 142 EUROPE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 143 EUROPE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 144 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 145 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 146 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 147 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 148 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 149 GERMANY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 150 GERMANY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 151 GERMANY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 152 GERMANY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 153 GERMANY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 154 GERMANY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 155 GERMANY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 156 GERMANY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 157 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 158 GERMANY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 159 GERMANY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 160 GERMANY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 161 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 162 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 163 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 164 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 165 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 166 FRANCE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 167 FRANCE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 168 FRANCE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 169 FRANCE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 170 FRANCE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 171 FRANCE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 172 FRANCE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 173 FRANCE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 174 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 175 FRANCE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 176 FRANCE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 177 FRANCE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 178 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 179 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 180 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 181 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 182 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 183 U.K. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 184 U.K. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 185 U.K. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 186 U.K. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 187 U.K. LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 188 U.K. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 189 U.K. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 190 U.K. LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 191 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 192 U.K. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 193 U.K. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 194 U.K. UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 195 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 196 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 197 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 198 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 199 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 200 ITALY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 201 ITALY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 202 ITALY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 203 ITALY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 204 ITALY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 205 ITALY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 206 ITALY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 207 ITALY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 208 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 209 ITALY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 210 ITALY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 211 ITALY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 212 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 213 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 214 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 215 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 216 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 217 SPAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 218 SPAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 219 SPAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 220 SPAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 221 SPAIN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 222 SPAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 223 SPAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 224 SPAIN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 225 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 226 SPAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 227 SPAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 228 SPAIN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 229 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 230 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 231 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 232 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 233 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 234 SWITZERLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 235 SWITZERLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 236 SWITZERLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 237 SWITZERLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 238 SWITZERLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 239 SWITZERLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 240 SWITZERLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 241 SWITZERLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 242 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 243 SWITZERLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 244 SWITZERLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 245 SWITZERLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 246 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 247 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 248 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 249 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 250 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 251 NETHERLANDS AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 252 NETHERLANDS AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 253 NETHERLANDS PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 254 NETHERLANDS SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 255 NETHERLANDS LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 256 NETHERLANDS GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 257 NETHERLANDS GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 258 NETHERLANDS LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 259 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 260 NETHERLANDS PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 261 NETHERLANDS MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 262 NETHERLANDS UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 263 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 264 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 265 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 266 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 267 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 268 BELGIUM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 269 BELGIUM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 270 BELGIUM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 271 BELGIUM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 272 BELGIUM LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 273 BELGIUM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 274 BELGIUM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 275 BELGIUM LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 276 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 277 BELGIUM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 278 BELGIUM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 279 BELGIUM UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 280 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 281 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 282 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 283 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 284 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 285 DENMARK AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 286 DENMARK AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 287 DENMARK PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 288 DENMARK SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 289 DENMARK LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 290 DENMARK GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 291 DENMARK GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 292 DENMARK LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 293 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 294 DENMARK PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 295 DENMARK MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 296 DENMARK UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 297 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 298 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 299 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 300 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 301 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 302 RUSSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 303 RUSSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 304 RUSSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 305 RUSSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 306 RUSSIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 307 RUSSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 308 RUSSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 309 RUSSIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 310 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 311 RUSSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 312 RUSSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 313 RUSSIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 314 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 315 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 316 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 317 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 318 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 319 SWEDEN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 320 SWEDEN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 321 SWEDEN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 322 SWEDEN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 323 SWEDEN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 324 SWEDEN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 325 SWEDEN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 326 SWEDEN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 327 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 328 SWEDEN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 329 SWEDEN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 330 SWEDEN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 331 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 332 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 333 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 334 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 335 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 336 TURKEY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 337 TURKEY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 338 TURKEY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 339 TURKEY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 340 TURKEY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 341 TURKEY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 342 TURKEY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 343 TURKEY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 344 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 345 TURKEY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 346 TURKEY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 347 TURKEY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 348 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 349 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 350 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 351 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 352 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 353 POLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 354 POLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 355 POLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 356 POLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 357 POLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 358 POLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 359 POLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 360 POLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 361 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 362 POLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 363 POLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 364 POLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 365 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 366 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 367 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 368 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 369 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 370 FINLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 371 FINLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 372 FINLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 373 FINLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 374 FINLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 375 FINLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 376 FINLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 377 FINLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 378 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 379 FINLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 380 FINLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 381 FINLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 382 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 383 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 384 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 385 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 386 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 387 NORWAY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 388 NORWAY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 389 NORWAY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 390 NORWAY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 391 NORWAY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 392 NORWAY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 393 NORWAY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 394 NORWAY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 395 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 396 NORWAY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 397 NORWAY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 398 NORWAY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 399 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 400 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 401 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 402 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 403 REST OF EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 404 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 405 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 406 ASIA-PACIFIC AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 407 ASIA-PACIFIC AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 408 ASIA-PACIFIC PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 409 ASIA-PACIFIC SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 410 ASIA-PACIFIC LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 411 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 412 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 413 ASIA-PACIFIC LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 414 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 415 ASIA-PACIFIC PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 416 ASIA-PACIFIC MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 417 ASIA-PACIFIC UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 418 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 419 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 420 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 421 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 422 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 423 CHINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 424 CHINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 425 CHINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 426 CHINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 427 CHINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 428 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 429 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 430 CHINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 431 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 432 CHINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 433 CHINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 434 CHINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 435 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 436 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 437 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 438 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 439 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 440 JAPAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 441 JAPAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 442 JAPAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 443 JAPAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 444 JAPAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 445 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 446 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 447 JAPAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 448 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 449 JAPAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 450 JAPAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 451 JAPAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 452 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 453 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 454 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 455 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 456 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 457 INDIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 458 INDIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 459 INDIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 460 INDIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 461 INDIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 462 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 463 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 464 INDIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 465 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 466 INDIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 467 INDIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 468 INDIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 469 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 470 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 471 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 472 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 473 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 474 AUSTRALIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 475 AUSTRALIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 476 AUSTRALIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 477 AUSTRALIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 478 AUSTRALIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 479 AUSTRALIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 480 AUSTRALIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 481 AUSTRALIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 482 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 483 AUSTRALIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 484 AUSTRALIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 485 AUSTRALIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 486 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 487 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 488 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 489 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 490 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 491 SOUTH KOREA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 492 SOUTH KOREA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 493 SOUTH KOREA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 494 SOUTH KOREA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 495 SOUTH KOREA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 496 SOUTH KOREA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 497 SOUTH KOREA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 498 SOUTH KOREA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 499 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 500 SOUTH KOREA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 501 SOUTH KOREA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 502 SOUTH KOREA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 503 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 504 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 505 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 506 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 507 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 508 THAILAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 509 THAILAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 510 THAILAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 511 THAILAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 512 THAILAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 513 THAILAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 514 THAILAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 515 THAILAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 516 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 517 THAILAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 518 THAILAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 519 THAILAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 520 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 521 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 522 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 523 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 524 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 525 SINGAPORE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 526 SINGAPORE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 527 SINGAPORE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 528 SINGAPORE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 529 SINGAPORE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 530 SINGAPORE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 531 SINGAPORE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 532 SINGAPORE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 533 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 534 SINGAPORE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 535 SINGAPORE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 536 SINGAPORE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 537 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 538 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 539 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 540 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 541 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 542 INDONESIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 543 INDONESIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 544 INDONESIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 545 INDONESIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 546 INDONESIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 547 INDONESIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 548 INDONESIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 549 INDONESIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 550 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 551 INDONESIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 552 INDONESIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 553 INDONESIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 554 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 555 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 556 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 557 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 558 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 559 MALAYSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 560 MALAYSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 561 MALAYSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 562 MALAYSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 563 MALAYSIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 564 MALAYSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 565 MALAYSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 566 MALAYSIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 567 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 568 MALAYSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 569 MALAYSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 570 MALAYSIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 571 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 572 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 573 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 574 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 575 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 576 NEW ZEALAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 577 NEW ZEALAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 578 NEW ZEALAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 579 NEW ZEALAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 580 NEW ZEALAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 581 NEW ZEALAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 582 NEW ZEALAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 583 NEW ZEALAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 584 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 585 NEW ZEALAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 586 NEW ZEALAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 587 NEW ZEALAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 588 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 589 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 590 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 591 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 592 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 593 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 594 VIETNAM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 595 VIETNAM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 596 VIETNAM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 597 VIETNAM LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 598 VIETNAM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 599 VIETNAM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 600 VIETNAM LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 601 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 602 VIETNAM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 603 VIETNAM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 604 VIETNAM UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 605 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 606 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 607 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 608 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 609 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 610 PHILIPPINES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 611 PHILIPPINES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 612 PHILIPPINES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 613 PHILIPPINES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 614 PHILIPPINES LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 615 PHILIPPINES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 616 PHILIPPINES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 617 PHILIPPINES LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 618 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 619 PHILIPPINES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 620 PHILIPPINES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 621 PHILIPPINES UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 622 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 623 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 624 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 625 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 626 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 627 TAIWAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 628 TAIWAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 629 TAIWAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 630 TAIWAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 631 TAIWAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 632 TAIWAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 633 TAIWAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 634 TAIWAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 635 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 636 TAIWAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 637 TAIWAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 638 TAIWAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 639 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 640 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 641 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 642 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 643 REST OF ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 644 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 645 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 646 SOUTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 647 SOUTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 648 SOUTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 649 SOUTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 650 SOUTH AMERICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 651 SOUTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 652 SOUTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 653 SOUTH AMERICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 654 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 655 SOUTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 656 SOUTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 657 SOUTH AMERICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 658 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 659 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 660 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 661 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 662 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 663 BRAZIL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 664 BRAZIL AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 665 BRAZIL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 666 BRAZIL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 667 BRAZIL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 668 BRAZIL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 669 BRAZIL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 670 BRAZIL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 671 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 672 BRAZIL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 673 BRAZIL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 674 BRAZIL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 675 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 676 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 677 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 678 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 679 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 680 ARGENTINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 681 ARGENTINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 682 ARGENTINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 683 ARGENTINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 684 ARGENTINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 685 ARGENTINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 686 ARGENTINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 687 ARGENTINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 688 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 689 ARGENTINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 690 ARGENTINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 691 ARGENTINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 692 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 693 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 694 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 695 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 696 REST OF SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 697 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 698 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 699 MIDDLE EAST AND AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 700 MIDDLE EAST AND AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 701 MIDDLE EAST AND AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 702 MIDDLE EAST AND AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 703 MIDDLE EAST AND AFRICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 704 MIDDLE EAST AND AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 705 MIDDLE EAST AND AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 706 MIDDLE EAST AND AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 707 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 708 MIDDLE EAST AND AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 709 MIDDLE EAST AND AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 710 MIDDLE EAST AND AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 711 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 712 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 713 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 714 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 715 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 716 SOUTH AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 717 SOUTH AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 718 SOUTH AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 719 SOUTH AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 720 SOUTH AFRICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 721 SOUTH AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 722 SOUTH AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 723 SOUTH AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 724 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 725 SOUTH AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 726 SOUTH AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 727 SOUTH AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 728 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 729 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 730 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 731 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 732 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 733 SAUDI ARABIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 734 SAUDI ARABIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 735 SAUDI ARABIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 736 SAUDI ARABIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 737 SAUDI ARABIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 738 SAUDI ARABIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 739 SAUDI ARABIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 740 SAUDI ARABIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 741 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 742 SAUDI ARABIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 743 SAUDI ARABIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 744 SAUDI ARABIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 745 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 746 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 747 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 748 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 749 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 750 BAHRAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 751 BAHRAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 752 BAHRAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 753 BAHRAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 754 BAHRAIN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 755 BAHRAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 756 BAHRAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 757 BAHRAIN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 758 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 759 BAHRAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 760 BAHRAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 761 BAHRAIN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 762 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 763 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 764 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 765 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 766 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 767 UNITED ARAB EMIRATES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 768 UNITED ARAB EMIRATES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 769 UNITED ARAB EMIRATES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 770 UNITED ARAB EMIRATES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 771 UNITED ARAB EMIRATES LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 772 UNITED ARAB EMIRATES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 773 UNITED ARAB EMIRATES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 774 UNITED ARAB EMIRATES LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 775 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 776 UNITED ARAB EMIRATES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 777 UNITED ARAB EMIRATES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 778 UNITED ARAB EMIRATES UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 779 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 780 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 781 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 782 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 783 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 784 KUWAIT AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 785 KUWAIT AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 786 KUWAIT PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 787 KUWAIT SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 788 KUWAIT LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 789 KUWAIT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 790 KUWAIT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 791 KUWAIT LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 792 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 793 KUWAIT PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 794 KUWAIT MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 795 KUWAIT UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 796 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 797 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 798 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 799 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 800 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 801 QATAR AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 802 QATAR AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 803 QATAR PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 804 QATAR SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 805 QATAR LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 806 QATAR GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 807 QATAR GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 808 QATAR LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 809 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 810 QATAR PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 811 QATAR MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 812 QATAR UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 813 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 814 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 815 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 816 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 817 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 818 EGYPT AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 819 EGYPT AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 820 EGYPT PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 821 EGYPT SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 822 EGYPT LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 823 EGYPT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 824 EGYPT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 825 EGYPT LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 826 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 827 EGYPT PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 828 EGYPT MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 829 EGYPT UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 830 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 831 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 832 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 833 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 834 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 835 OMAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 836 OMAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 837 OMAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 838 OMAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 839 OMAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 840 OMAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION)

TABLE 841 OMAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION)

TABLE 842 OMAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 843 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 844 OMAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 845 OMAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 846 OMAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 847 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 848 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION)

TABLE 849 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION)

TABLE 850 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 851 REST OF MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Medical Foods for Inborn Errors of Metabolism Market is segmented by Products, Age Group, Diseases, Forms, Packaging, and Distribution Channel
North America dominates the medical foods for inborn errors of metabolism market because of the presence of well-developed healthcare infrastructure and favourable reimbursement policies in the region.
The Medical Foods for Inborn Errors of Metabolism market grows at a CAGR of 13.5% & is to reach USD 6,717.76 million by 2030 from USD 2,477.81 million in 2022.
Major market players operating in the global medical foods for inborn errors of metabolism market are Nestlé Health Science (A subsidiary of Nestle), Nutricia (A subsidiary of Danone), Baxter, Meiji Holdings Co., Ltd., Piam Farmaceutici S.P.A., Solace Nutrition, Abbott, Mead Johnson & Company, LLC. (A Subsidiary of Reckitt Benckiser Group plc.), Ajinomoto Cambrooke, Inc. (A Subsidiary of Ajinomoto Co., Inc.), Galen Limited, PKU-MDmil, Pristine Organics Private Limited, APR, Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA), PKU Perspectives, EBM Medical, Orpharma Pty Ltd., B. Braun SE, Primus Pharmaceuticals, Inc., Kate Farms, Hexagonnutrition Ltd., Ener-G Foods, Inc., Promin Metabolics, and Dr. Schär AG / SPA) among others.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Poland, Finland, Denmark, Sweden, Norway, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, New Zealand, Vietnam, Philippines, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, Bahrain, United Arab Emirates, Kuwait, Qatar, Egypt, Oman, and Rest of Middle East and Africa.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials